Pharmas despised slightly less than insurers, says poll

Share this article:
Americans blame health insurance companies more than pharmas for problems with the US healthcare system – but not by much.

An August Harris Interactive poll of 2,498 US adults found that 90% of respondents blame insurers for the state of American healthcare, with 60% saying insurers deserve a “great deal of blame.” But pharmaceutical companies were right behind them in the blame game, with 84% of respondents saying the drug industry is to blame and 53% assigning it a great deal of the blame.

Next up: Republicans in Congress (74%); business (72%); hospitals (70%); Democrats in Congress (69%); former President George W. Bush (66%); and doctors (61%).

The poll found a 49% to 40% plurality of adults in support of President Obama's proposed healthcare reform. That compares to a 50% to 20% plurality in favor as of January.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...